After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
KRYS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Krystal Biotech Inc is $4.87B. A total of 0.3 million shares were traded on the day, compared to an average of 284.25K shares.
In the most recent transaction, Krishnan Suma sold 25,000 shares of KRYS for 177.79 per share on Mar 13 ’25. After the transaction, the President, R&D now owns 1,533,056 company shares. In a previous transaction on Mar 13 ’25, Krishnan Suma sold 25,000 shares at 177.79 per share. KRYS shares that President, R&D owns now total 1,463,711.
Among the insiders who sold shares, Krishnan Krish S disposed of 25,000 shares on Mar 13 ’25 at a per-share price of $177.79. This resulted in the President and CEO holding 1,533,056 shares of KRYS after the transaction. In another insider transaction, Krishnan Krish S sold 25,000 shares at $177.79 per share on Mar 13 ’25. Company shares held by the President and CEO now total 1,463,711.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, KRYS has a high of $219.34 and a low of $141.72.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. KRYS’s latest balance sheet shows that the firm has $438.10M in Cash & Short Term Investments as of fiscal 2021. There were $8.02M in debt and $25.74M in liabilities at the time. Its Book Value Per Share was $32.87, while its Total Shareholder’s Equity was $593.58M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KRYS is Buy with a score of 4.82.
